{
    "nctId": "NCT02166281",
    "briefTitle": "Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "Endocrine Responsive Early Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "The number of participants who suffer from insomnia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with a histological diagnosis of invasive operated breast cancer (any pT, any pN)\n* Women with more than 60 years\n* Women less than 60 years with amenorrhea for at least 12 months and FSH and estradiol values in the range of menopause\n* Signature of written informed consent.\n\nExclusion Criteria:\n\n* Locally advanced or metastatic disease (M1)\n* A history of breast cancer or other cancers diagnosed in the last 10 years, to exception of basal cell carcinoma or squamous cell carcinoma of the skin or carcinoma in situ of the cervix\n* History of severe osteoporosis before the diagnosis of breast cancer\n* Bisphosphonate therapy before the diagnosis of breast cancer\n* Other serious medical conditions that could limit the ability of the patient to participate in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}